Cognitive impairment following breast cancer treatments: an umbrella review

被引:13
作者
Oliva, Giulia [1 ,2 ]
Giustiniani, Andreina [2 ]
Danesin, Laura [2 ]
Burgio, Francesca [2 ]
Arcara, Giorgio [2 ]
Conte, Pierfranco [2 ]
机构
[1] Univ Padua, Dept Surg Oncol & Gastroenterol DiSCOG, I-35124 Padua, Italy
[2] IRCCS, San Camillo Hosp, I-30126 Venice, Italy
关键词
breast cancer; cancer treatments; cognitive impairment; objective cognitive deficits; subjective cognitive concerns; quality of life; QUALITY-OF-LIFE; ENDOCRINE THERAPY; COLORECTAL-CANCER; ADJUVANT THERAPY; OLDER PATIENTS; CHEMOTHERAPY; SURVIVORS; WOMEN; DYSFUNCTION; PREVALENCE;
D O I
10.1093/oncolo/oyae090
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives Cancer-related cognitive impairment (CRCI) refers to a cognitive decline associated with cancer or its treatments. While research into CRCI is expanding, evidence remains scattered due to differences in study designs, methodologies, and definitions. The present umbrella review aims to provide a comprehensive overview of the current evidence regarding the impact of different breast cancer therapies on cognitive functioning, with a particular focus on the interplay among objective cognitive deficits (ie, measured with standardized tests), subjective cognitive concerns, (ie, self-reported), and other mediating psycho-physical factors.Methods The search was made in Pubmed, Embase, and Scopus for articles published until July 2023, following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analysis protocol.Results Chemotherapy and endocrine therapy appear consistently associated with CRCI in patients with breast cancer, primarily affecting memory, attention/concentration, executive functioning, and processing speed. Subjective cognitive concerns were often found weakly or not associated with neuropsychological test results, while overall CRCI seemed consistently associated with psychological distress, fatigue, sleep quality, and inflammatory and biological factors.Conclusion Current evidence suggests that CRCI is common after chemotherapy and endocrine therapy for breast cancer. However, heterogeneity in study designs and the scarcity of studies on more recent treatments such as targeted therapies and immunotherapies, highlight the need for more systematic and harmonized studies, possibly taking into account the complex and multifactorial etiology of CRCI. This may provide valuable insights into CRCI's underlying mechanisms and potential new ways to treat it. This review provides a comprehensive overview of the current evidence regarding the impact of different breast cancer therapies on cognitive functioning, with a particular focus on the interplay among objective cognitive deficits, subjective cognitive concerns, and other mediating psycho-physical factors.
引用
收藏
页码:e848 / e863
页数:16
相关论文
共 86 条
[1]  
AGRAWAL K, 2010, MATURITAS, V67, P209, DOI DOI 10.1016/J.MATURITAS.2010.07.004
[2]   The Impact of Endocrine Therapy on Cognitive Functions of Breast Cancer Patients: A Systematic Review [J].
Bakoyiannis, Ioannis ;
Tsigka, Eleousa-Alexandra ;
Perrea, Despina ;
Pergialiotis, Vasilios .
CLINICAL DRUG INVESTIGATION, 2016, 36 (02) :109-118
[3]   Synergistic Chemotherapy for Breast Cancer and Breast Cancer Brain Metastases via Paclitaxel-Loaded Oleanolic Acid Nanoparticles [J].
Bao, Youmei ;
Zhang, Shenqi ;
Chen, Zeming ;
Chen, Ann T. ;
Ma, Junning ;
Deng, Gang ;
Xu, Weiguo ;
Zhou, Jiangbing ;
Yu, Zhi-Qiang ;
Yao, Guangyu ;
Chen, Jianjun .
MOLECULAR PHARMACEUTICS, 2020, 17 (04) :1343-1351
[4]   Effect of screening and adjuvant therapy on mortality from breast cancer [J].
Berry, DA ;
Cronin, KA ;
Plevritis, SK ;
Fryback, DG ;
Clarke, L ;
Zelen, M ;
Mandelblatt, JS ;
Yakovlev, AY ;
Habbema, JDF ;
Feuer, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1784-1792
[5]  
Bherer Louis, 2013, J Aging Res, V2013, P197326, DOI [10.1155/2013/657508, 10.1155/2013/197326]
[6]   Women's experiences of cancer-related cognitive impairment, its impact on daily life and care received for it following treatment for breast cancer [J].
Bolton, Gaby ;
Isaacs, Anton .
PSYCHOLOGY HEALTH & MEDICINE, 2018, 23 (10) :1261-1274
[7]   Perceived Cognitive Impairment in Breast Cancer Survivors and Its Relationships with Psychological Factors [J].
Boscher, Clemence ;
Joly, Florence ;
Clarisse, Benedicte ;
Humbert, Xavier ;
Grellard, Jean-Michel ;
Binarelli, Giulia ;
Tron, Laure ;
Licaj, Idlir ;
Lange, Marie .
CANCERS, 2020, 12 (10) :1-13
[8]   Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment [J].
Bray, Victoria J. ;
Dhillon, Haryana M. ;
Vardy, Janette L. .
JOURNAL OF CANCER SURVIVORSHIP, 2018, 12 (04) :537-559
[9]   Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study [J].
Cerulla, Noemi ;
Arcusa, Angels ;
Navarro, Jose-Blas ;
Garolera, Maite ;
Enero, Cristina ;
Chico, Gloria ;
Fernandez-Morales, Luis .
BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (01) :179-187
[10]   Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy [J].
Cerulla Torrente, Noemi ;
Navarro Pastor, Jose-Blas ;
de la Osa Chaparro, Nuria .
JOURNAL OF CANCER SURVIVORSHIP, 2020, 14 (04) :464-482